Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols.
Oxidized low-density lipoproteins play important roles in the development of atherosclerosis and contain several lipid-derived, bioactive molecules which are believed to contribute to atherogenesis. Of these, some cholesterol oxidation products, referred to as oxysterols, are suspected to favor the formation of atherosclerotic plaques involving cytotoxic, pro-oxidant and pro-inflammatory processes. Ten commonly occurring oxysterols (7alpha-, 7beta-hydroxycholesterol, 7-ketocholesterol, 19-hydroxycholesterol, cholesterol-5alpha,6alpha-epoxide, cholesterol-5beta,6beta-epoxide, 22R-, 22S-, 25-, and 27-hydroxycholesterol) were studied for both their cytotoxicity and their ability to induce superoxide anion production (O2*-) and IL-8 secretion in U937 human promonocytic leukemia cells. Cytotoxic effects (phosphatidylserine externalization, loss of mitochondrial potential, increased permeability to propidium iodide, and occurrence of cells with swollen, fragmented and/or condensed nuclei) were only identified with 7beta-hydroxycholesterol, 7-ketocholesterol and cholesterol-5beta,6beta-epoxide, which also induce lysosomal destabilization associated or not associated with the formation of monodansylcadaverine-positive cytoplasmic structures. No relationship between oxysterol-induced cytotoxicity and HMG-CoA reductase activity was found. In addition, the highest O2*- overproduction quantified with hydroethidine was identified with 7beta-hydroxycholesterol, 7-ketocholesterol and cholesterol-5beta,6beta-epoxide, with cholesterol-5alpha, 6alpha-epoxide and 25-hydroxycholesterol. The highest capacity to simultaneously stimulate IL-8 secretion (quantified by ELISA and by using a multiplexed, particle-based flow cytometric assay) and enhance IL-8 mRNA levels (determined by RT-PCR) was observed with 7beta-hydroxycholesterol and 25-hydroxycholesterol. None of the effects observed for the oxysterols were detected for cholesterol. Therefore, oxysterols may have cytotoxic, oxidative, and/or inflammatory effects, or none whatsoever.
Lemaire-Ewing
S
S
Inserm U498, Métabolisme des Lipoprotéines Humaines et Interactions Vasculaires, CHU/Hôpital du Bocage, Dijon, France.
Prunet
C
C
Montange
T
T
Vejux
A
A
Berthier
A
A
Bessède
G
G
Corcos
L
L
Gambert
P
P
Néel
D
D
Lizard
G
G
D000214:Acyl Coenzyme A / Q000378:metabolism; D002463:Cell Membrane Permeability / Q000187:drug effects; D002784:Cholesterol / Q000031:analogs & derivatives* / Q000502:physiology / Q000633:toxicity*; D003593:Cytoplasm / Q000378:metabolism; D006801:Humans; D006888:Hydroxycholesterols / Q000633:toxicity; D016209:Interleukin-8 / Q000096:biosynthesis / Q000235:genetics; D008564:Membrane Potentials / Q000187:drug effects; D051336:Mitochondrial Membranes / Q000187:drug effects; D010084:Oxidation-Reduction; D010718:Phosphatidylserines / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis; D013481:Superoxides / Q000378:metabolism; D020298:U937 Cells
D000214:Acyl Coenzyme A; D006888:Hydroxycholesterols; D016209:Interleukin-8; D010718:Phosphatidylserines; D012333:RNA, Messenger; D013481:Superoxides; C008047:3-hydroxy-3-methylglutaryl-coenzyme A; D002784:Cholesterol